2005
DOI: 10.1007/s11940-005-0008-0
|View full text |Cite
|
Sign up to set email alerts
|

Current treatment of nystagmus

Abstract: Acquired and congenital nystagmus often causes decreased visual acuity as a direct result of the inability to maintain stable foveal vision. In addition, acquired nystagmus causes a disabling subjective sensation of movement of the visual world called oscillopsia. The eye movements themselves do not require treatment if the patient is asymptomatic. However, therapy is necessary if visual disability is present. Treatments based in pharmacologic mechanisms are preferred. There are few controlled treatment trials… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2007
2007
2025
2025

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(16 citation statements)
references
References 49 publications
0
16
0
Order By: Relevance
“…[72][73][74] In the year of 2001, Young et. al 75 have shown that clonazepam is 100% effective in treatment of 5 patients with idiopathic downbeat nystagmus.…”
Section: Benzodiazepinesmentioning
confidence: 99%
“…[72][73][74] In the year of 2001, Young et. al 75 have shown that clonazepam is 100% effective in treatment of 5 patients with idiopathic downbeat nystagmus.…”
Section: Benzodiazepinesmentioning
confidence: 99%
“…2 Hertle et al 3 reported that horizontal rectus tenotomy could result in improvement of subjective visual function and nystagmus amplitude in patients with congenital nystagmus. The authors postulated that the clinical and electrophysiological effects of extraocular muscle tenotomy in patients with congenital nystagmus have been attributed to an interruption of the afferent proprioceptive loop, resulting in a damped peripheral ocular motor response to the nystagmus signal.…”
Section: Commentmentioning
confidence: 99%
“…The authors have brought both memantine and gabapentin squarely into the growing armamentarium of pharmacologic approaches to the treatment of CIN and, to a lesser extent, acquired nystagmus [1,2]. Most of the recommendations for drug treatment of nystagmus are made on the basis of "by-guess-and by-golly" utilization of drugs based on individual case reports and small patient series.…”
Section: Editor's Commentsmentioning
confidence: 99%
“…Such reports provide the stimulus for randomized, prospective, double-masked studies such as this one. Other drugs, including 3, 4 diaminopyridine, 4-aminopyridine, clonazepam, valproate, and baclofen, have been studied and need larger trials to determine their firm place in treating nystagmus [1]. In the meantime, other techniques, including surgical approaches, contact lenses, and the use of prisms, are alternatives to medication [3,4].…”
Section: Editor's Commentsmentioning
confidence: 99%